JONES PUBLIC AFFAIRS, INC. for THE SAFDAR GROUP (ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES)
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 20, 2012 | — | Replaced |
| 4th Quarter - Amendment (this page) | Jul 17, 2013 | — | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH DANUSER | Intern for U.S. Senator Kent Conrad |
Health Issues HCR
Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH DANUSER | Intern for U.S. Senator Kent Conrad |
Trade (domestic/foreign) TRD
Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH DANUSER | Intern for U.S. Senator Kent Conrad |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.